Endocrinology

Top Story

Omega-3 fatty acid supplementation does not affect insulin resistance in PCOS

July 25, 2016

Women with polycystic ovary syndrome likely receive no benefit from daily omega-3 fatty acid supplementation, according to a meta-analysis of three randomized controlled trials.

“Reducing the levels of serum insulin and increasing insulin sensitivity are considered to be of paramount importance for therapeutic targets in PCOS,” Alirez Sadeghi, of the department of cellular and molecular nutrition at the School of Nutritional Sciences and Dietetics at Tehran University of Medical Sciences, Iran, and colleagues wrote. “Omega-3 fatty acids may lead to insulin sensitivity by producing and secreting anti-inflammatory adipokines, such as adiponectin, and also through reducing inflammation and proinflammatory cytokines. Although it is said that omega-3 fatty acids have positive effects on insulin resistance, various studies have indicated contradictory results.”

Flu vaccination reduces respiratory, CV hospitalizations for patients with diabetes

July 25, 2016
Patients with type 2 diabetes who received influenza vaccination appeared to experience fewer hospitalizations due to respiratory infection or cardiovascular events than…

Lymphocytic thyroiditis yields high prevalence of benign cervical lymph nodes

July 25, 2016
Fewer central neck compartment metastatic lymph nodes and more reactive benign cervical lymph nodes were found in patients with lymphocytic thyroiditis compared with…
FDA News

Orphan drug status granted for therapy to prevent post-transplantation pancreatic islet loss

July 25, 2016
The FDA granted an orphan drug designation to Araim Pharmaceuticals for its Innate Repair Receptor activator ARA 290, according to a press release. ARA 290 is intended…
In the Journals

HPS2-THRIVE analysis: Adding niacin with laropiprant to statin reduced survival, increased costs

July 25, 2016
Quality of life-adjusted survival was reduced and hospital costs rose due to the addition of extended-release niacin with laropiprant to statin-based therapy, according…
More News Headlines »
CME

Obesity Consults® ObesityForum® 2015 Highlights

This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc. and Novo Nordisk, Inc.

Obesity has increased dramatically in the past 20 years and is considered a health care epidemic in the United States…
More »
Video
Meeting News Coverage

VIDEO: Measure glucose, not HbA1c

June 15, 2016
More »
Featured
Highlights from ADA

Highlights from ADA

CME

Managing Obesity in 2015: Setting the Framework and Assessing All of the Options

This activity is supported by an educational grant from Novo Nordisk.

This CME activity is based on the slides and lectures presented by the faculty at the symposium, Managing Obesity in…
More »
Current Issues
View the Current Issues